Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

NVOH vs. EFA: which is better?

Bottom line

NVOH vs EFA: the short answer

NVOH (Novo Nordisk A/S (B Shares) ADRhedged) and EFA (iShares MSCI EAFE ETF) are both etfs.

But EFA is far broader, holding 691 positions to 3 for NVOH, so beyond the top names it adds exposure NVOH doesn't have.

NVOH is cheaper at 0.19% vs 0.32% — a difference of $13 a year per $10,000 invested.

Updated Nov 19, 2026

NVOH vs EFA side by side

NVOHEFA
TypeETFETF
Fund familyDWS (Xtrackers)iShares
CategoryInternational StockInternational Stock
Expense ratio0.19%0.32%
Annual cost per $10k$19$32
10-yr cost on $10k (prospectus)$243$406
Max front loadNoneNone
12b-1 fee0%0%
1-yr return—+3.4%
5-yr return (annualized)—+4.7%
10-yr return (annualized)—+5.1%
Best quarter—+18.1%
Worst quarter—−22.9%
Net assets (fund)$4.2M$78.0B
Number of holdings3691
Portfolio turnover%4%
Returns as of—Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

NVOH and EFA share none of their top holdings.

NVOH top 10

  1. Novo Nordisk A/s — 96.87%
  2. Dreyfus Trsry Securities — 2.79%
  3. Canadian Imperial Bank Of Commerce — -0.08%

EFA top 10

  1. ASML Holding N.V. — 2.90%
  2. Hsbc Holdings Plc — 1.66%
  3. Roche Holding AG — 1.39%
  4. Novartis AG — 1.30%
  5. Nestle S.A. — 1.17%
  6. Shell Plc — 1.17%
  7. Astrazeneca Plc — 1.17%
  8. Siemens Aktiengesellschaft — 1.10%
  9. Mitsubishi UFJ Financial Group, Inc. — 1.08%
  10. Bhp Group Limited — 0.97%

FAQ

What is the difference between NVOH and EFA?
NVOH (Novo Nordisk A/S (B Shares) ADRhedged) and EFA (iShares MSCI EAFE ETF) are both etfs. But EFA is far broader, holding 691 positions to 3 for NVOH, so beyond the top names it adds exposure NVOH doesn't have.
Which is cheaper, NVOH or EFA?
NVOH has the lower expense ratio (0.19%).
Should I own both NVOH and EFA?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.